Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.39 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.32 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.32 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.32 |
| ▸ | RET | P07949 | 2/20 | 0.32 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.32 |
| ▸ | FLT1 | P17948 | 2/20 | 0.32 |
| ▸ | LTK | P29376 | 2/20 | 0.32 |
| ▸ | GRK5 | P34947 | 2/20 | 0.32 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.32 |
| ▸ | CDK8 | P49336 | 2/20 | 0.32 |
| ▸ | CDK7 | P50613 | 2/20 | 0.32 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperazine SCHEMBL28119295 | 1.00 | KDR (0.43) | KDRHIF1AMAPTPDE4ACRBN | |
| SCHEMBL3991717 | 1.00 | KDR (0.43) | KDRHIF1AMAPTPDE4ACRBN | |
| Piperazine SCHEMBL28231072 | 0.97 | KDR (0.40) | KDRHIF1AMAPTPDE4ACRBN | |
| SCHEMBL31059 | 0.89 | — | — | |
| SCHEMBL21785045 | 0.89 | CRBN (0.47) | KDRMAPTCRBNSMN1; SMN2CHEK1 | |
| SCHEMBL9058472 | 0.89 | CRBN (0.47) | KDRMAPTCRBNSMN1; SMN2CHEK1 | |
| SCHEMBL8217380 | 0.88 | CXCR4 (0.50) | KDRHIF1AMAPTPDE4ACRBN | |
| Pyrrolidine SCHEMBL20271397 | 0.87 | ALDH1A1 (0.47) | KDRCRBNCXCR4SMN1; SMN2CHEK1 | |
| Hydrochloric Acid SCHEMBL5740143 | 0.85 | CRBN (0.44) | KDRMAPTCRBNSMN1; SMN2CHEK1 | |
| SCHEMBL2672858 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200075998-A1 | CYCLIC COMPOUND, ANODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2020-03-05 | — | — | US | disclosed |
| US-20200058955-A1 | ANODE FOR LITHIUM ION SECONDARY BATTEERY AND LITHIUM ION SECONDARY BATTERY | HYDRO-QUéBEC (CA) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200075998-A1 | CYCLIC COMPOUND, ANODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | CLK2, CLK4, CACNA2D3 | KDR 4727/4885HIF1A 4623/4885MAPT 3114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.